Dergiler / Erciyes Medical Journal / 2021 / Cilt: 43 - Sayı: 1

Efficacy and Safety of Myrtol® Standardized in theTreatment of Acute and Chronic Rhinosinusitis: A Review of Literature

Sayfa
3–8
Yayın Tarihi
2022-10-11
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Therefore, this study reviewed randomized studiesrelated to its use in the treatment of upper-airway inflammations and discussed the mechanisms of action of this herbal drugon infected nasal and paranasal sinuses mucosa.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:The clinical pattern of rhinosinusitis is based on key symptoms, such as nasal obstruction/congestion, nasal secretion withpostnasal discharge, facial pain with pressure, and impaired sense of smell.
📊
Temel Bulgular & Veri:Chronic rhinosinusitisis an inflammatory disease of the sinonasal mucosa with symptoms persisting for more than 12 weeks.
💡
Sonuç & Katkı:Therefore, this study reviewed randomized studiesrelated to its use in the treatment of upper-airway inflammations and discussed the mechanisms of action of this herbal drugon infected nasal and paranasal sinuses mucosa.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

The clinical pattern of rhinosinusitis is based on key symptoms, such as nasal obstruction/congestion, nasal secretion withpostnasal discharge, facial pain with pressure, and impaired sense of smell. Acute rhinosinusitis is a viral infection commonlycaused by impaired paranasal sinus aeration and drainage and can progress to bacterial superinfection. Chronic rhinosinusitisis an inflammatory disease of the sinonasal mucosa with symptoms persisting for more than 12 weeks. This paper aimedto summarize and update the literature related to the use of herbal product Myrtol® standardized in the treatment of acuteand chronic rhinosinusitis. Earlier investigations have demonstrated that Myrtol® standardized has strong secretolytic, se cretomotoric, anti-inflammatory, antioxidative, and antimicrobial effects. Therefore, this study reviewed randomized studiesrelated to its use in the treatment of upper-airway inflammations and discussed the mechanisms of action of this herbal drugon infected nasal and paranasal sinuses mucosa.

🔖

Bu Makaleye Atıf Yap

PERİC, A. V., PERİC, A., KOSAK, T. S., ALEKSİC, A., BARSOVA, G. K. (2022). Efficacy and Safety of Myrtol® Standardized in theTreatment of Acute and Chronic Rhinosinusitis: A Review of Literature. Erciyes Medical Journal, Cilt: 43 - Sayı: 1, 3–8. https://ajindex.com/articles/502330

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. A summary for otorhinolaryngologists. Rhinology 2012; 50(1): 1–12
  2. Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology 2020; 58(Suppl S29): 1–464
  3. Orlandi RR, Kingdom TT, Hwang PH, Smith TL, Alt JA, Baroody FM, Batra PS, et al. International Consensus Statement on Allergy and Rhinology: Rhinosinusitis. Int Forum Allergy Rhinol 2016; 6(Suppl 1) S1–213
  4. Park JJ, Bachert C, Dazert S, Kostev K, Seidel DU. Current healthcare pathways in the treatment of rhinosinusitis in Germany. Acta Otolaryngol 2018; 138(12): 1086–91
  5. Perić A, Gaćeša D. Etiology and pathogenesis of chronic rhinosinusitis. Vojnosanit Pregl 2009; 65(9): 699–702
  6. Eccles R. Mechanisms of the symptoms of rhinosinusitis. Rhinology 2011; 49(2): 131–8
  7. Stupar M, Špreng D, Perić A. Application of questionnaires in the assessment of clinical severity of chronic rhinosinusitis. Vojnosanit Pregl 2020; 77(2): 182–8
  8. Laccourreye O, Werner A, Laccourreye L, Bonfils P. Benefits, pitfalls and risks of phytotherapy in clinical practice in otorhinolaryngology. Eur Ann Otorhinolaryngol Head Neck Dis 2017; 134(2): 95–9
  9. Perić A, Vezmar Kovačević S, Gaćeša D, Perić AV. Efficacy and safety of combined treatment of acute rhinosinusitis by herbal medicinal product Sinupret and mometasone furoate nasal spray. ENT Updates 2017; 7(2): 68–74
  10. Paparoupa M, Gillissen A. Is Myrtol® standardized a new alternative toward antibiotics? Pharmacogn Rev 2016; 10(20): 143–6
  11. Guo R, Canter PH, Ernst E. Herbal medicines for the treatment of rhinosinusitis: a systematic review. Otolaryngol Head Neck Surg 2006; 135(4): 496–506
  12. Perić A. The use of herbal drugs in therapy of acute and chronic rhinosinusitis. In: Perić A, Perić AV, Baletić N, Vukomanović Đurđević B, editors. Medical treatment of rhinitis and rhinosinusitis. 1st ed. Belgrade: Medija Centar Odbrana; 2019.p.141–54
  13. Zimmermann T, Seiberling M, Thomann P, Karabelnik D. The relative bioavailability and pharmacokinetics of standardized myrtol. [Article in German]. Arzneimittelforschung 1995; 45(11): 1198–201
  14. Begrow F, Böckenholt C, Ehmen M, Wittig T, Verspohl EJ. Effect of Myrtol standardized and other substances on the respiratory tract: ciliary beat frequency and mucociliary clearance as parameters